CRISPR Therapeutics AG
Hedge Funds Holdings
Last updated:
CRISPR Therapeutics AG‘s stocks are currently a part of 418 hedge funds’ portfolios, which represents 62.72% of the total amount of its stocks outstanding. This makes up a total of 50.41M shares of CRISPR Therapeutics AG. Compared to the previous quarter, the number grew by 17.69% or 7.57M shares more. As for the holding position changes, 38.52% (161) of current hedge fund investors increased the number of shares held, 22.01% (92) of current holders sold a part of the shares held, and 17.22% (72) closed the holdings completely. 69 hedge funds are new holders of CRISPR Therapeutics AG stock in Q1 2022, it is 16.51% of total holders.
Hedge funds holding CRISPR Therapeutics AG (Q2 2017 – Q1 2022)
| Q2 2017 | 39 |
|---|---|
| Q3 2017 | 61 |
| Q4 2017 | 82 |
| Q1 2018 | 134 |
| Q2 2018 | 172 |
| Q3 2018 | 176 |
| Q4 2018 | 151 |
| Q1 2019 | 166 |
| Q2 2019 | 177 |
| Q3 2019 | 178 |
| Q4 2019 | 250 |
| Q1 2020 | 254 |
| Q2 2020 | 269 |
| Q3 2020 | 304 |
| Q4 2020 | 403 |
| Q1 2021 | 430 |
| Q2 2021 | 486 |
| Q3 2021 | 458 |
| Q4 2021 | 434 |
| Q1 2022 | 418 |
Hedge funds changes in CRISPR Therapeutics AG positions (Q2 2017 – Q1 2022)
| Q2 2017 | 10 | 5 | 8 | 6 | 10 |
|---|---|---|---|---|---|
| Q3 2017 | 26 | 14 | 5 | 4 | 12 |
| Q4 2017 | 36 | 21 | 10 | 15 | 0 |
| Q1 2018 | 65 | 33 | 26 | 12 | -2 |
| Q2 2018 | 70 | 51 | 31 | 31 | -11 |
| Q3 2018 | 45 | 47 | 39 | 42 | 3 |
| Q4 2018 | 28 | 40 | 43 | 51 | -11 |
| Q1 2019 | 38 | 44 | 36 | 22 | 26 |
| Q2 2019 | 41 | 44 | 35 | 29 | 28 |
| Q3 2019 | 31 | 51 | 51 | 29 | 16 |
| Q4 2019 | 91 | 67 | 52 | 19 | 21 |
| Q1 2020 | 47 | 95 | 56 | 43 | 13 |
| Q2 2020 | 60 | 91 | 61 | 44 | 13 |
| Q3 2020 | 70 | 95 | 86 | 31 | 22 |
| Q4 2020 | 139 | 129 | 90 | 39 | 6 |
| Q1 2021 | 105 | 172 | 94 | 74 | -15 |
| Q2 2021 | 111 | 167 | 122 | 52 | 34 |
| Q3 2021 | 57 | 190 | 113 | 80 | 18 |
| Q4 2021 | 73 | 161 | 123 | 94 | -17 |
| Q1 2022 | 69 | 161 | 92 | 72 | 24 |
Hedge funds changes in CRISPR Therapeutics AG stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 1,000 | 322,000 |
|---|---|---|
| Q3 2017 | 27,000 | 983,000 |
| Q4 2017 | 3,230,000 | 1,561,000 |
| Q1 2018 | 8,405,000 | 30,389,000 |
| Q2 2018 | 29,738,000 | 76,289,000 |
| Q3 2018 | 20,216,000 | 46,728,000 |
| Q4 2018 | 11,405,000 | 17,510,000 |
| Q1 2019 | 14,057,000 | 21,632,000 |
| Q2 2019 | 30,628,000 | 26,422,000 |
| Q3 2019 | 23,874,000 | 22,850,000 |
| Q4 2019 | 55,593,000 | 58,170,000 |
| Q1 2020 | 41,454,000 | 31,787,000 |
| Q2 2020 | 76,780,585 | 88,711,000 |
| Q3 2020 | 64,697,000 | 66,418,000 |
| Q4 2020 | 294,456,000 | 278,370,000 |
| Q1 2021 | 360,457,730 | 405,356,400 |
| Q2 2021 | 514,071,000 | 598,939,281 |
| Q3 2021 | 294,869,000 | 415,858,862 |
| Q4 2021 | 231,897,050 | 210,277,000 |
| Q1 2022 | 148,875,782 | 155,813,050 |